Skip to main content
SpringerLink
Log in

Vitamine und Spurenelemente

Substitution bei Dialysepatienten

Vitamins and trace elements

Substitution for dialysis patients

  • CME Weiterbildung · Zertifizierte Fortbildung
  • Published:
Der Nephrologe Aims and scope

Zusammenfassung

Dialysepatienten leiden oft unter Malnutrition und einem Mangel an Mikronährstoffen. Eine der Ursachen scheint die Elimination wasserlöslicher Vitamine während der Dialyse zu sein. Häufig kommt dabei eine Mangel an Vitamin C, Folsäure und Vitamin B6 vor. Die Spurenelemente, die am häufigstsen niedrig sind, sind Eisen, Zink und Selen. Defizite dieser Substanzen führen meist zu subtilen, unspezifischen Störungen. Durch den Mangel an Antioxidantien könnte die atherosklerotische Herzkrankheit begünstigt werden. In der Übersicht werden die aktuellen Empfehlungen zur Substitution von Vitaminen und Spurenelementen aufgeführt.

Abstract

Patients on maintenance dialysis may suffer from micronutrient deficiencies and malnutrition, especially due to the elimination of water-soluble vitamins during dialysis. Vitamins which may be low in these patients include vitamin C, folate, and vitamin B6. Common trace element deficiencies comprise iron, zinc, and selenium. These deficits may cause subtle and nonspecific manifestations. Inadequate levels of antioxidants also may lead to the development of atherosclerotic cardiovascular disease. We review the requirements for vitamins and trace element supplements.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. (n a) (2005) K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45:16–153

  2. (n a) (2006) KIDOQI Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47:516–585

  3. Akiba T, Kurihara S, Tachibana K (1991) Vitamin K increased bone mass in hemodialysis patients with low turn over bone disease. J Am Soc Nephrol 2:608

    Google Scholar 

  4. Billion S, Tribout B, Cadet E (2002) Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: Effect of oral therapy with folic acid and vitamin B12. Nephrol Dial Transplant 17:455–461

    Article  CAS  PubMed  Google Scholar 

  5. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C (2004) Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 364:1219–1228

    Article  CAS  PubMed  Google Scholar 

  6. Boaz M, Smetena S, Weinstein T et al (2009) Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE): randomised placebo-controlled trials. Lancet 356:1213–1218

    Article  Google Scholar 

  7. Chazot C, Kopple JD (2004) Vitamin metabolism and requirements in renal disease and renal failure. In: Kopple JD, Massry SG (eds) Nutritional management of renal disease. Lipincott Williams & Wilkins, Philadelphia, S315–S356

  8. Curhan GC, Mitch WE (2008) Diet and kidney disease. In: Brenner, Barry M (eds) Brenner & Rector’s The kidney. Saunders/Elsevier, Philadelphia

  9. DeBari VA, Frank O, Baker H, Needle MA (1984) Water soluble vitamins in granulocytes, erythrocytes and plasma obtained from chronic hemodialysis patients. Am J Clin Nutr 39:410–415

    CAS  PubMed  Google Scholar 

  10. Deicher R, Ziai F, Habicht A et al (2004) Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis. Nephrol Dial Transplant 19:2319–2324

    Article  CAS  PubMed  Google Scholar 

  11. Descombes, E, Hanck AB, Fellay G (1993) Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int 43:1319–1328

    Article  CAS  PubMed  Google Scholar 

  12. Elian KM, Hoffer LJ (2002) Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease. Metabolism 51:881–886

    Article  CAS  PubMed  Google Scholar 

  13. Fissell RB, Bragg-Gresham JL, Gillespie BW et al (2004) International variation in vitamin prescription and association with mortality in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 44:293–299

    Article  CAS  PubMed  Google Scholar 

  14. Fouque D, Vennegoor M, Ter Wee P et al (2007) EBPG guideline on nutrition. Nephrol Dial Transplant 22:ii45–ii87

    Article  PubMed  Google Scholar 

  15. Gonin JM, Nguyen H, Gonin R (2003) Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD. J Nephrol 16:522–534

    CAS  PubMed  Google Scholar 

  16. Ihara M, Ito T, Yanagihara C (1999) Wernicke’s encephalopathy associated with hemodialysis: Report of two cases and review of the literature. Clin Neurol Neurosurg 101:118–121

    Article  CAS  PubMed  Google Scholar 

  17. Jagadha V, Deck JH, Halliday WC (1987) Wernicke’s encephalopathy in patients on peritoneal dialysis or hemodialysis. Ann Neurol 21:78–84

    Article  CAS  PubMed  Google Scholar 

  18. Jha P, Flather M, Lonn E et al (1995) The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 123:860–872

    CAS  PubMed  Google Scholar 

  19. Kalantar-Zadeh K, Kopple JD (2003) Trace elements and vitamins in maintenance dialysis patients. Adv Ren Replace Ther 10:170–182

    Article  PubMed  Google Scholar 

  20. Kasama R, Koch T, Canals-Navas C, Pitone JM (1996) Vitamin B6 and hemodialysis: The impact of high-flux/highefficiency dialysis and review of the literature. Am J Kidney Dis 27:686

    Article  Google Scholar 

  21. Khajehdehi P, Mojerlou M, Behzadi S et al (2001) A randomized double blind placebo controlled trial of supplementary vitamin E, C and their combination for treatment of haemodialysis cramps. Nephrol Dial Transplant 16:1448–1451

    Article  CAS  PubMed  Google Scholar 

  22. Kohlmeier M, Saupe J, Shearer MJ (1997) Bone health of adult hemodialysis patients is related to vitamin K status. Kidney Int 51:1218–1221

    Article  CAS  PubMed  Google Scholar 

  23. Kopple JD, Swendseid ME (1975) Vitamin nutrition in patients undergoing maintenance hemodialysis. Kidney Int Suppl 2:S78–S84

    Google Scholar 

  24. Lipschitz DA, Bothwell TH, Seftel HC et al (1971) The role of ascorbic acid in the metabolism of storage iron. Br J Haematol 20:155–163

    Article  CAS  PubMed  Google Scholar 

  25. Masud T (2005) Trace elements and vitamins in renal disease. In: Mitch WE, Klahr S (eds) Handbook of nutrition and the kidney. Lippincott Williams & Wilkins, Philadelphia, pp 196–217

  26. Mydlik M, Derzsiova K, Zemberova E (1997) Metabolism of vitamin B6 and its requirement in chronic renal failure. Kidney Int 52:S56–S59

    Google Scholar 

  27. Ono K (1986) Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients. Clin Nephrol 26:239–243

    CAS  PubMed  Google Scholar 

  28. Pronai W, Riegler-Keil M, Silberbauer K (1995) Folic acid supplementation improves erythropoietin response. Nephron 71:395–400

    Article  CAS  PubMed  Google Scholar 

  29. Robinson K, Gupta A, Dennis V (1996) Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 94:2478

    Google Scholar 

  30. Russel MR, Suter P (2008) Vitamin and trace mineral deficiency and excess. In: Fauci AS, Kasper D, Longo D, Braunwald E (eds) Harrison’s principles of internal medicine. McGraw-Hill, New York

  31. Schaumburg H, Kaplan J, Winderbank A (1983) Sensory neuropathy from pyridoxine abuse: A new megavitamin syndrome. N Engl J Med 309:445–489

    Article  CAS  PubMed  Google Scholar 

  32. Sullivan JF, Eisenstein AB, Mottola OM, Mittal AK (1972) The effect of dialysis on plasma and tissue levels of vitamin C. Trans Am Soc Artif Intern Organs 18:277–282

    CAS  PubMed  Google Scholar 

  33. Sunder-Plassmann G, Fodinger M, Buchmayer H (2000) Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: Results of the Vienna multicenter study. J Am Soc Nephrol 11:1106–1116

    CAS  PubMed  Google Scholar 

  34. Takahashi Y, Tanaka A, Nakamura T et al (2004) Nicotinamide suppresses hyperphosphatemia in hemodialysis patients. Kidney Int 65:1099–1104

    Article  CAS  PubMed  Google Scholar 

  35. Tremblay R, Bonnardeaux A, Geadah D et al (2000) Hyperhomocysteinemia in hemodialysis patients: Effects of the 12-month supplementation with hydrosoluble vitamins. Kidney Int 58:851–858

    Article  CAS  PubMed  Google Scholar 

  36. Vivekananthan DP, Penn MS, Sapp SK et al (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361:2017–2023

    Article  CAS  PubMed  Google Scholar 

  37. Wang S, Eide TC, Sogn EM et al (1999) Plasma ascorbic acid in patients undergoing chronic haemodialysis. Eur J Clin Pharmacol 55:527–532

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Abteilung für Nephrologie, Klinikum rechts der Isar, Ismaningerstr. 22, 81675, München, Deutschland

    I. Murgan

Authors
  1. I. Murgan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Murgan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murgan, I. Vitamine und Spurenelemente . Nephrologe 5, 251–260 (2010). https://doi.org/10.1007/s11560-009-0395-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-009-0395-4

Schlüsselwörter

Keywords

Search

Navigation